Press Releases

ROSEMONT, Ill., Dec. 18, 2019 /PRNewswire/ -- The American Association of Oral and Maxillofacial Surgeons (AAOMS) and the Henry Schein Cares Foundation are supporting the volunteer service of four oral and maxillofacial surgeons (OMSs) through the joint Global Outreach Program.For the fifth consecutive year, AAOMS and the Foundation are presenting

STOCKHOLM, Dec. 18, 2019 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR) today announces that the first patient has been enrolled and is being dosed with remetinostat gel 1% in an investigator-initiated phase II clinical study in patients with squamous cell carcinoma (SCC). This clinical study is conducted at the Stanford University

STOCKHOLM, Dec. 18, 2019 /PRNewswire/ --  The press conference held in connection with the publication of Essity's Year-end Report for 2019 will also be available via webcast and it is possible to join by phone.The Year-end Report will be published on January 22, 2020 at approximately 07:00 CET

LUND, Sweden, Dec. 18, 2019 /PRNewswire/ -- BioInvent International AB ("BioInvent" or the "Company") (OMXS: BINV) today announces that it has entered into a clinical trial collaboration and supply agreement with MSD, a tradename of Merck & Co., Inc., Kenilworth, NJ., USA, to evaluate the combination of BioInvent's BI-1206, one o

OSLO, Norway, Dec. 18, 2019 /PRNewswire/ -- Nordic Nanovector ASA (OSE: NANO) announces that its research and development project Nanoyield has received a non-dilutive funding of NOK 12 million (USD 1.3 million) from the Norwegian Research Council (Forskningsrådet).The Nanoyield project is aimed at

LAVAL, Quebec, Dec. 17, 2019 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") announced today that it has priced its previously announced offering of $1,250,000,000 aggregate principal amount of 5.000% senior notes due 2028 (the "2028 Notes") and $1,250,000,000 aggr

WINNIPEG, Dec. 17, 2019 /PRNewswire/ - Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH, OTC:MCUJF), a cardiovascular pharmaceutical company, is pleased to announce the completion of the Shortened AGGRASTAT® (tirofiban hydrochloride) injection versus Integrilin® (eptifibatide) in Percutaneous Coronary Intervention (SAVI-PCI) Clinical Tr

Rebrand provides strategic clarity on Company's position as a global leader in the end-to-end development and manufacturing of cannabinoid-based productsSolidifies the Company's evolution in expertise, from extraction to innovative, next generation products focused on delivering customized user experiences Signals commitment to enter high-value i

TORONTO, Dec. 17, 2019 /PRNewswire/ - ADVANZ PHARMA Corp. ("ADVANZ PHARMA" or "the Company") (TSX: ADVZ), a global pharmaceutical company focused on serving the needs of patients and healthcare providers around the world with enhanced access to high quality, niche-established medicines, today announced that shareholders voted 97.3 per cent in favour of a special res

SOUTH SAN FRANCISCO, Calif., Dec. 17, 2019 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), today announced that Eldon Mayer has resigned from his position as chief commercial officer effective December 23, 2019, to pursue an opportunity with an emerging company. "We would like to thank E